An approach for developing a blood-based screening panel for lung cancer based on clonal hematopoietic mutations. Anandakrishnan R, Shahidi R, Dai A, Antony V, et al. PLoS One 2024;19:e0307232.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Anandakrishnan R, Shahidi R, Dai A, Antony V, et al. An approach for developing a blood-based screening panel for lung cancer based on clonal hematopoietic mutations. PLoS One 2024;19:e0307232.
PMID: 39172974